| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Content in Vascular Smooth Muscles
Denver Research Institute (P.A.W., J.E.-B.R.), Denver Veterans Affairs Medical Center and Department of Medicine (P.A.W., A.N., J.E.-B.R.), Division of Endocrinology, University of Colorado Health Sciences Center, Denver, Colorado 80220; and National Cancer Institute (C.V.), National Institutes of Health, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Jane E.-B. Reusch, M.D., Denver VA Medical Center, Room 9C-120, 1055 Clermont Street, Denver, Colorado 80220. E-mail: . jane.reusch{at}uchsc.edu
Experiments in vascular smooth muscle cells (SMCs) indicate that the transcription factor cAMP response element-binding protein (CREB), the cyclic nucleotide response element-binding protein, suppresses expression of the platelet-derived growth factor-
receptor gene (PDGFR
). Adenovirus-mediated expression of constitutively active CREB mutants decreases PDGFR
mRNA, PDGFR
protein, and PDGFR
promoter-luciferase reporter activity in cultured SMCs. Expression of dominant negative CREB protein, A-CREB, increases PDGFR
protein content and the PDGFR
-promoter activity in SMCs. Active CREB prevents activation of PDGFR
promoter-luciferase reporter activity by CCAAT/enhancer-binding protein-
(C/EBP
), shown to mediate IL-1ß stimulation of PDGFR
expression. Exposure of cultured SMCs to high glucose or reactive oxidant stress, which decrease CREB protein content and activity, increases PDGFR
protein content and promoter activity. Expression of active CREB blunts reactive oxidant stress-induced PDGFR
accumulation in SMCs. Loss of CREB protein in aortic walls of rats with streptozotocin-induced diabetes is accompanied by an increase in PDGFR
content. In Ob/Ob mice (which demonstrate reduced aortic wall CREB content vs. Ob/- controls), treatment with the peroxisomal proliferator-activated receptor
rosiglitazone increases CREB content and decreases PDGFR
content in the aortic wall. Thus, both in vitro and in vivo loss of CREB content and activity and subsequent accumulation of PDGFR
may contribute to SMC activation during diabetes.
This article has been cited by other articles:
![]() |
P. A. Watson, J. E. B. Reusch, S. A. McCune, L. A. Leinwand, S. W. Luckey, J. P. Konhilas, D. A. Brown, A. J. Chicco, G. C. Sparagna, C. S. Long, et al. Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H246 - H259. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nomiyama, T. Nakamachi, F. Gizard, E. B. Heywood, K. L. Jones, N. Ohkura, R. Kawamori, O. M. Conneely, and D. Bruemmer The NR4A Orphan Nuclear Receptor NOR1 Is Induced by Platelet-derived Growth Factor and Mediates Vascular Smooth Muscle Cell Proliferation J. Biol. Chem., November 3, 2006; 281(44): 33467 - 33476. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Najwer and B. Lilly Ca2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements Am J Physiol Cell Physiol, October 1, 2005; 289(4): C785 - C793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E.B. Reusch and D. J. Klemm Cyclic AMP Response Element-Binding Protein in the Vessel Wall: Good or Bad? Circulation, September 9, 2003; 108(10): 1164 - 1166. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |